Alkermes is interested in contributing to independent education through grants. Our particular focus this year includes educational activities with pragmatic approaches to improve patient care and public health in the domains of schizophrenia, alcohol and opioid dependence, and depression. We expect to contribute to a better understanding of the treatment in a broader sense including psychosocial methods as well as medications. Alkermes’ grant funds may not be used to support overhead expenses of the applicant or for any other institution affiliated with the applicant.
Examples of appropriate requestors of education grants include, but are not limited to:
Education grants will not be awarded to or for:
Alkermes is committed to complying with all applicable regulations and codes pertaining to education grants. Alkermes follows the requirements of the Compliance Program Guidance for Pharmaceutical Manufacturers issued by the Department of Health and Human Services Office of the Inspector General (“OIG Guidelines”), the Pharmaceutical Research and Manufacturers of America Code on Interactions with Healthcare Professionals (“PhRMA Code”), the FDA Guidance to Industry Supported Scientific and Educational Activities, and the Accreditation Council for Continuing Medical Education (“ACCME”) Standards for Commercial Support. Alkermes does not provide support for education programs that are intended to encourage, induce, or influence any grant recipient to purchase, prescribe, refer, recommend, sell, administer, or arrange for the purchase, sale or recommendation, or formulary placement of any Alkermes’ product.
To submit an education grant request, please register and submit your completed application and supporting documentation through Alkermes’ education grant management system located here.